《Neurotherapeutics》雜志的最新年發文量為108篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在臨床神經病學領域的學術影響力。
該刊聚焦于醫學-臨床神經病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Neurotherapeutics 雜志發文統計
文章名稱引用次數
- Anxiety, Depression, and the Microbiome: A Role for Gut Peptides54
- Gut Microbiota and the Neuroendocrine System37
- Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan34
- Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses28
- Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action26
- LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway25
- Pompe Disease: From Basic Science to Therapy22
- Diet, Gut Microbiota, and Vitamins D plus A in Multiple Sclerosis20
- Microbiota Signaling Pathways that Influence Neurologic Disease20
- Inhibition of miR-155 Limits Neuroinflammation and Improves Functional Recovery After Experimental Traumatic Brain Injury in Mice19
國家/地區發文量
- USA589
- England81
- Canada72
- CHINA MAINLAND65
- GERMANY (FED REP GER)57
- Italy38
- Switzerland36
- Australia33
- France26
- Spain20
